L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey-Reference-Cited by-同舟云学术

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey

Published:2017-10-09 Issue:12 Volume:24 Page:1532-1538
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Perez-Lloret S.¹²^ORCID,Negre-Pages L.³⁴,Damier P.⁵,Delval A.⁶,Derkinderen P.⁵,Destée A.⁶,Meissner W. G.⁷,Tison F.⁷,Rascol O.¹,

Affiliation:

1. INSERM; Services de Pharmacologie Clinique et Neurosciences; Centre d'Investigation Clinique CIC 1436; NS-Park/FCRIN Network; NeuroToul COEN Center; Université de Toulouse UPS; CHU de Toulouse; Toulouse France

2. Institute of Cardiology Research; University of Buenos Aires; National Research Council (CONICET-ININCA); Buenos Aires Argentina

3. LN Pharma; Toulouse

4. Département d'Information Médicale; Unité de Recherche Clinique et Epidémiologie; Hôpital la Colombière; Montpellier

5. Department of Neurology; INSERM; NS-Park/FCRIN Network; Université de Nantes; CHU de Nantes; Nantes

6. Department of Neurology; INSERM; NS-Park/FCRIN Network; Université de Lille; CHU de Lille; U 837 Eq6; Lille

7. CNRS, CHU de Bordeaux; Institut des Maladies Neurodégénératives; UMR 5293; Service de Neurologie; NS-Park/FCRIN Network; Université de Bordeaux; Bordeaux France

Funder

Association France Parkinson

ADREN

Boehringer Ingelheim, Eisai, Faust Pharmaceuticals, GlaxoSmithKline, Pierre Fabre Médicaments, Solvay Pharma and Wyeth Lederlé

LN PHARMA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.13466/fullpdf

Reference38 articles.